Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
February 8, 2022
Patent Application Number
16108018
Date Filed
August 21, 2018
Patent Citations
Patent Primary Examiner
Patent abstract
The present disclosure provides antibodies that bind to human CD137 or antigen binding fragments thereof, nucleic acid encoding the same, therapeutic compositions thereof, and their use to enhance T-cell function to upregulate cell-mediated immune responses and for the treatment of T cell dysfunctional disorders, such as tumor immunity, and for the treatment of cancer.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
